| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LogicBio Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | $2.01 | 16 Nov 2022 | Direct | |
| LogicBio Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 0 | 16 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LOGC | LogicBio Therapeutics, Inc. | 16 Nov 2022 | 2 | $0 | 4 | Chief Medical Officer | 17 Nov 2022, 20:02 |
| LOGC | LogicBio Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Chief Medical Officer | 03 Mar 2022, 17:07 |
| LOGC | LogicBio Therapeutics, Inc. | 06 Aug 2021 | 3 | -$6,381 | 4 | Chief Medical Officer | 10 Aug 2021, 18:31 |
| LOGC | LogicBio Therapeutics, Inc. | 19 May 2021 | 1 | $0 | 4 | Chief Medical Officer | 20 May 2021, 20:36 |
| LOGC | LogicBio Therapeutics, Inc. | 19 May 2021 | 0 | $0 | 3 | Chief Medical Officer | 20 May 2021, 20:33 |